---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-166858"
form_type: "8-K"
ticker: "KURA"
cik: "0001422143"
company_name: "Kura Oncology, Inc."
filed_at: "2023-06-14T23:59:59+00:00"
generated_at: "2026-06-14T01:05:45.712118+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Kura Oncology prices $100M public offering of common stock and pre-funded warrants

## Summary
- Offering of 5,660,871 common shares at $11.50 and 3,034,782 pre-funded warrants at $11.4999 per warrant.
- Expected net proceeds of $93.6M; closing on June 16, 2023.
- Underwriters granted 30-day option to buy up to 1,304,347 additional shares.
- BofA Securities, Jefferies and SVB Securities are joint bookrunning managers.

## SEC filing metadata
- accession: 0001193125-23-166858
- form_type: 8-K
- ticker: KURA
- cik: 0001422143
- company_name: Kura Oncology, Inc.
- filed_at: 2023-06-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1422143/000119312523166858/0001193125-23-166858-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1422143/000119312523166858/d507995d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-166858
- JSON: https://secwatch.observer/filing/0001193125-23-166858.json
- Plain text: https://secwatch.observer/filing/0001193125-23-166858.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.